AME Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
AMETEK is a solid long-term company, but based on the current data it is not a strong immediate buy for a beginner investor who is impatient and wants to deploy $50,000-$100,000 right now. The fundamentals are good, analysts are mostly constructive, and the latest quarter was strong, but the stock is trading near a key pivot with mixed short-term momentum, no special Intellectia buy signal, and recent congress trading shows more selling than buying. My direct view: hold for now rather than buy immediately.
AME is in a mildly bullish longer-term structure, with SMA_5 > SMA_20 > SMA_200, which supports an uptrend. MACD histogram is positive at 0.0955, but it is contracting, so upside momentum is not accelerating. RSI_6 at 52.57 is neutral, showing neither oversold nor overbought conditions. Price at 234 is close to pivot support at 233.39, with resistance at 240.71 and 245.24. Short-term trend data is mixed, with only limited near-term upside expectations and no clear breakout signal.
["Q1 revenue grew 11.34% year over year to 1.93B", "Net income rose 13.53% year over year and EPS increased 14.47%", "Gross margin improved to 43.08%", "Truist raised its target to 275 and kept Buy after a strong Q1 beat", "Mizuho raised its target to 270 and kept Outperform", "New acquisition of Indicor Instrumentation could add growth and scale", "Organic orders rose 22%, showing strong demand in aerospace, defense, automation, and engineered solutions"]
["Shares were down in the latest session, with regular market change at -2.75%", "MACD momentum is positive but weakening", "RSI is neutral, so the stock is not showing a strong timing setup", "No AI Stock Picker signal and no SwingMax signal", "Hedge funds and insiders are neutral with no significant buying trend", "Congress trading shows 1 sale and 0 purchases in the past 90 days", "Large acquisition introduces integration and capital deployment complexity"]
In Q1 2026, AMETEK delivered strong results: revenue increased to 1.928B, up 11.34% year over year; net income rose to 399.4M, up 13.53%; EPS came in at 1.74, up 14.47%; and gross margin expanded to 43.08%, up 3.66 points year over year. This is a healthy growth quarter and supports the long-term story.
Analyst sentiment is generally positive but not unanimous. Truist, Mizuho, and BMO are constructive, with Truist raising its target to 275 and reiterating Buy, while Baird and Morgan Stanley remain more cautious with Neutral/Equal Weight views. Barclays is also cautious at Equal Weight. Overall, the Street sees AME as a quality industrial with good execution and upside, but there is still a balanced-to-mixed view on near-term valuation and cyclicality.
